Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of David G Ginzinger
Introduction
David G Ginzinger is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of molecular biology, particularly in the area of DNA quantification. His work has implications for diagnostics and treatment options in various medical conditions.
Latest Patents
Ginzinger holds a patent for a "Quantitative PCR method to enumerate DNA copy number." This invention provides rapid and inexpensive methods for determining the copy number of a test locus of interest. The methods involve monitoring the formation of amplification products using real-time amplification detection systems to quantify the amount of test locus and reference loci in a test subject, as well as in at least one control subject. The applicability of these methods extends to interrogating the copy number of loci containing simple sequence repeats, which are common in eukaryotic genomes. This innovation serves as a diagnostic and prognostic tool, correlating abnormal copy number values for specific loci with diseases and the effectiveness of different treatment options.
Career Highlights
Ginzinger is affiliated with the University of California, where he continues to advance research in molecular biology. His work has garnered attention for its potential to improve diagnostic methods and treatment strategies in healthcare.
Collaborations
He has collaborated with notable colleagues, including Tony E Godfrey and Ronald H Jensen, contributing to a rich environment of innovation and research.
Conclusion
David G Ginzinger's contributions to the field of molecular biology through his innovative patent demonstrate the importance of advancements in DNA quantification methods. His work continues to influence diagnostic and therapeutic approaches in medicine.